Pharvaris N.V. SEC filings PHVS
Pharvaris N.V. has 327 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form 20-F, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 8, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 26, 2026 | Jun 26, 2026 |
| 6-K | Current report (foreign issuer) | Jun 11, 2026 | Jun 11, 2026 |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
| 6-K | Current report (foreign issuer) | May 11, 2026 | May 11, 2026 |
| 6-K | Current report (foreign issuer) | Apr 2, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Jan 12, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Dec 3, 2025 | Dec 3, 2025 |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Sep 8, 2025 | Sep 8, 2025 |
| 6-K | Current report (foreign issuer) | Aug 12, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 24, 2025 | Jul 24, 2025 |
| 6-K | Current report (foreign issuer) | Jul 10, 2025 | Jul 10, 2025 |
| 6-K | Current report (foreign issuer) | Jun 27, 2025 | Jun 27, 2025 |
| 6-K | Current report (foreign issuer) | Jun 10, 2025 | Jun 10, 2025 |
| 6-K | Current report (foreign issuer) | May 13, 2025 | May 13, 2025 |
| 6-K | Current report (foreign issuer) | Apr 7, 2025 | Apr 7, 2025 |
| 6-K | Current report (foreign issuer) | Jan 13, 2025 | Jan 13, 2025 |
| 6-K | Current report (foreign issuer) | Nov 13, 2024 | Nov 13, 2024 |
| 6-K | Current report (foreign issuer) | Sep 25, 2024 | Sep 25, 2024 |
| 6-K | Current report (foreign issuer) | Sep 23, 2024 | Sep 23, 2024 |
| 6-K | Current report (foreign issuer) | Sep 5, 2024 | Sep 5, 2024 |
| 6-K | Current report (foreign issuer) | Aug 14, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jun 28, 2024 | Jun 28, 2024 |
| 6-K | Current report (foreign issuer) | Jun 11, 2024 | Jun 11, 2024 |
| 6-K | Current report (foreign issuer) | Jun 4, 2024 | Jun 4, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 10, 2024 | Apr 10, 2024 |
| 6-K | Current report (foreign issuer) | Mar 6, 2024 | Mar 6, 2024 |
| 6-K | Current report (foreign issuer) | Feb 16, 2024 | Feb 16, 2024 |
| 6-K | Current report (foreign issuer) | Feb 7, 2024 | Feb 7, 2024 |
| 6-K | Current report (foreign issuer) | Jan 22, 2024 | Jan 22, 2024 |
| 6-K | Current report (foreign issuer) | Jan 8, 2024 | Jan 8, 2024 |
| 6-K | Current report (foreign issuer) | Dec 8, 2023 | Dec 8, 2023 |
| 6-K | Current report (foreign issuer) | Dec 6, 2023 | Dec 6, 2023 |
| 6-K | Current report (foreign issuer) | Nov 2, 2023 | Nov 2, 2023 |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 3, 2023 | Jul 3, 2023 |
| 6-K | Current report (foreign issuer) | Jun 27, 2023 | Jun 27, 2023 |
| 6-K | Current report (foreign issuer) | Jun 26, 2023 | Jun 26, 2023 |
| 6-K | Current report (foreign issuer) | Jun 23, 2023 | Jun 23, 2023 |
| 6-K | Current report (foreign issuer) | Jun 20, 2023 | Jun 20, 2023 |
| 6-K | Current report (foreign issuer) | Jun 1, 2023 | Jun 1, 2023 |
| 6-K | Current report (foreign issuer) | May 8, 2023 | May 8, 2023 |
| 6-K | Current report (foreign issuer) | Apr 5, 2023 | Apr 5, 2023 |
| 6-K | Current report (foreign issuer) | Mar 10, 2023 | Mar 10, 2023 |
| 6-K | Current report (foreign issuer) | Mar 8, 2023 | Mar 8, 2023 |
| 6-K | Current report (foreign issuer) | Feb 14, 2023 | Feb 14, 2023 |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Dec 8, 2022 | Dec 8, 2022 |
| 6-K | Current report (foreign issuer) | Dec 8, 2022 | Dec 8, 2022 |
| 6-K | Current report (foreign issuer) | Nov 1, 2022 | Nov 1, 2022 |
| 6-K | Current report (foreign issuer) | Sep 12, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Aug 22, 2022 | Aug 22, 2022 |
| 6-K | Current report (foreign issuer) | Jul 13, 2022 | Jul 13, 2022 |
| 6-K/A | Filing | Jul 5, 2022 | Jul 1, 2022 |
| 6-K | Current report (foreign issuer) | Jun 29, 2022 | Jun 29, 2022 |
| 6-K | Current report (foreign issuer) | Jun 14, 2022 | Jun 14, 2022 |
| 6-K | Current report (foreign issuer) | May 11, 2022 | May 11, 2022 |
| 6-K | Current report (foreign issuer) | May 11, 2022 | May 11, 2022 |
| 6-K | Current report (foreign issuer) | Mar 29, 2022 | Mar 29, 2022 |
| 6-K | Current report (foreign issuer) | Jan 10, 2022 | Jan 10, 2022 |
| 6-K | Current report (foreign issuer) | Dec 22, 2021 | Dec 22, 2021 |
| 6-K | Current report (foreign issuer) | Dec 7, 2021 | Dec 7, 2021 |
| 6-K | Current report (foreign issuer) | Nov 10, 2021 | Nov 10, 2021 |
| 6-K | Current report (foreign issuer) | Jul 30, 2021 | Jul 30, 2021 |
| 6-K | Current report (foreign issuer) | Jul 1, 2021 | Jul 1, 2021 |
| 6-K | Current report (foreign issuer) | Jun 29, 2021 | Jun 29, 2021 |
| 6-K | Current report (foreign issuer) | Jun 11, 2021 | Jun 11, 2021 |
| 6-K | Current report (foreign issuer) | May 26, 2021 | May 26, 2021 |
| 6-K | Current report (foreign issuer) | May 12, 2021 | May 12, 2021 |
| 6-K/A | Filing | May 3, 2021 | Apr 30, 2021 |
| 6-K | Current report (foreign issuer) | Apr 29, 2021 | Apr 29, 2021 |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PHVS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Leiden
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1830487
- Former names
- Pharvaris, B.V. (until Feb 4, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.